|
|||||
|
|
Improvement in health‐related quality of life in patients with haemophilia B treated with nonacog beta pegol,a new extended half‐life recombinant FIX product |
|
| Authors: | P. Chowdary S. Kearney A. Regnault C. S. Hoxer D. L. Yee |
| Affiliation: | 1. Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, UK;2. CHCMN Hemophilia and Thrombosis Center Children's Hospital and Clinics of Minnesota, Minneapolis, MN, USA;3. Patient‐Centered Outcomes, Mapi, Lyon, France;4. Novo Nordisk A/S, S?borg, Denmark;5. Department of Pediatrics, Hematology‐Oncology Section, Baylor College of Medicine, Texas Children's Hemophilia & Thrombosis Center, Houston, TX, USA |
| Abstract: | |
| Keywords: | factor IX haemophilia B nonacog beta pegol quality of life questionnaires |